Matches in Wikidata for { <http://www.wikidata.org/entity/Q99408643> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q99408643 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q99408643 description "scientific article published on 26 February 2020" @default.
- Q99408643 description "wetenschappelijk artikel" @default.
- Q99408643 description "наукова стаття, опублікована 26 лютого 2020" @default.
- Q99408643 name "Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials" @default.
- Q99408643 name "Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials" @default.
- Q99408643 type Item @default.
- Q99408643 label "Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials" @default.
- Q99408643 label "Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials" @default.
- Q99408643 prefLabel "Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials" @default.
- Q99408643 prefLabel "Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials" @default.
- Q99408643 P1433 Q99408643-6BCC5BFA-9E91-447C-990E-2B6CB1128D9B @default.
- Q99408643 P1476 Q99408643-C956BC51-F48D-4F89-B4AB-838A2D62A843 @default.
- Q99408643 P2093 Q99408643-0EB72901-F079-4B32-BFC1-3BC47AEF22BE @default.
- Q99408643 P2093 Q99408643-1DE0DB49-A836-4928-BD3C-DBFC3DD0B4AE @default.
- Q99408643 P2093 Q99408643-205608A7-C0CA-4893-A932-E6B5C7A12B22 @default.
- Q99408643 P2093 Q99408643-2535D58B-71E1-4699-888A-8570EE7AD965 @default.
- Q99408643 P2093 Q99408643-3A5AE27B-1762-4D8B-AB29-13E2A5FD9A9D @default.
- Q99408643 P2093 Q99408643-42493BEE-12C6-49A9-9004-51FAFE10563B @default.
- Q99408643 P2093 Q99408643-53D0AEB6-05AC-42A8-94C1-CA380BAF672D @default.
- Q99408643 P2093 Q99408643-6951060C-33D1-45E8-8A3E-9F8242E793E9 @default.
- Q99408643 P2093 Q99408643-82BDA1AC-AE9B-4927-95FA-B2628FC704B4 @default.
- Q99408643 P2093 Q99408643-88FEE136-24C0-454F-B559-2BA1B95D75B0 @default.
- Q99408643 P2093 Q99408643-93051195-56F7-461A-B461-99894ACCE086 @default.
- Q99408643 P2093 Q99408643-C342CF6D-C12A-4904-AEE3-1DF5068D9676 @default.
- Q99408643 P2093 Q99408643-C8819511-F39C-4B85-AF78-A234DCD023FF @default.
- Q99408643 P2093 Q99408643-EE26A65F-13C3-4ABA-8912-D64E0705CAFC @default.
- Q99408643 P2093 Q99408643-FE4F7F89-9465-4304-B234-24C132C599AA @default.
- Q99408643 P31 Q99408643-D6CB6188-C3D3-49F7-A119-332D4E622A8E @default.
- Q99408643 P356 Q99408643-64925C42-D027-4B46-8A5F-009FA3388853 @default.
- Q99408643 P478 Q99408643-1F750392-584B-4FF4-8EAE-42038AE5CDB0 @default.
- Q99408643 P50 Q99408643-68F89B37-8CC2-4F7D-9F3A-A5517CDE9E39 @default.
- Q99408643 P50 Q99408643-CAE5D061-C768-41AA-9129-BE1CB9147513 @default.
- Q99408643 P577 Q99408643-73415269-5E30-46AF-B317-47D25EFF7E17 @default.
- Q99408643 P698 Q99408643-EB614392-B47A-45AB-B306-533381D79C06 @default.
- Q99408643 P921 Q99408643-7A3BC74B-A531-4BEF-86D1-B82B8E4204E8 @default.
- Q99408643 P932 Q99408643-C1932284-A184-47B9-AF72-C14A62442898 @default.
- Q99408643 P356 PO.19.00237 @default.
- Q99408643 P698 32923882 @default.
- Q99408643 P1433 Q89051819 @default.
- Q99408643 P1476 "Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials" @default.
- Q99408643 P2093 "Ayman Zawadi" @default.
- Q99408643 P2093 "Aziz Zaanan" @default.
- Q99408643 P2093 "Catherine Julie" @default.
- Q99408643 P2093 "Daniel J Sargent" @default.
- Q99408643 P2093 "Enrico Mini" @default.
- Q99408643 P2093 "Frank A Sinicrope" @default.
- Q99408643 P2093 "Gunnar Folprecht" @default.
- Q99408643 P2093 "Jean Luc Van Laethem" @default.
- Q99408643 P2093 "Jeffrey P Meyers" @default.
- Q99408643 P2093 "Josep Tabernero" @default.
- Q99408643 P2093 "Julien Taieb" @default.
- Q99408643 P2093 "Karine Le Malicot" @default.
- Q99408643 P2093 "Pierre Laurent-Puig" @default.
- Q99408643 P2093 "Qian Shi" @default.
- Q99408643 P2093 "Richard M Goldberg" @default.
- Q99408643 P31 Q13442814 @default.
- Q99408643 P356 "10.1200/PO.19.00237" @default.
- Q99408643 P478 "4" @default.
- Q99408643 P50 Q64371564 @default.
- Q99408643 P50 Q88846398 @default.
- Q99408643 P577 "2020-02-26T00:00:00Z" @default.
- Q99408643 P698 "32923882" @default.
- Q99408643 P921 Q18555025 @default.
- Q99408643 P932 "7446392" @default.